Cost analysis for efficient management: Diabetes treatment at a public district hospital in Thailand

International Journal of Pharmacy Practice

Volumn 19, Issue 5, 2011, Pages 342-349

  Riewpaiboon, Arthorn ^a   Chatterjee, Susmita ^a,c   Piyauthakit, Piyanuch ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Waritchaphum Hospital   (Thailand)

^c PUBLIC HEALTH FOUNDATION OF INDIA   (India)

Author keywords

cost of illness; diabetes; provider perspective; Thailand

Indexed keywords

FUROSEMIDE; ISOPHANE INSULIN; PIG INSULIN;

ADULT; AGED; ARTICLE; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC NEPHROPATHY; FEMALE; HOSPITAL COST; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; ORGANIZATIONAL EFFICIENCY; OUTPATIENT; PRIORITY JOURNAL; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; THAILAND;

COSTS AND COST ANALYSIS; DIABETES MELLITUS; DISEASE MANAGEMENT; FEMALE; HEALTH CARE COSTS; HOSPITALS, DISTRICT; HOSPITALS, PUBLIC; HUMANS; MALE; MIDDLE AGED; MODELS, ECONOMIC;

EID: 80052564382     PISSN: 09617671     EISSN: 20427174     Source Type: Journal    
DOI: 10.1111/j.2042-7174.2011.00131.x     Document Type: Article

References (42)

1. Riewpaiboon A, et al,. Effect of costing methods on unit cost of hospital medical services. Trop Med Int Health 2007; 12: 554-563. (Pubitemid 46631146)
2. Riewpaiboon A, et al,. Predicting treatment cost for bacterial diarrhea at a regional hospital in Thailand. J Health Popul Nutr 2008; 26: 442-450.
3. Riewpaiboon A, et al,. A drug cost model for injuries due to road traffic accidents. Pharm Pract 2008; 6: 9-14. (Pubitemid 351586579)
4. Nitiyanant W, et al,. A survey study on diabetes management and complication status in primary care setting in Thailand. J Med Assoc Thai 2007; 90: 65-71.
5. Rawdaree P, et al,. Thailand diabetes registry (TDR) project: clinical status and long term vascular complications in diabetic patients. J Med Assoc Thai 2006; 89 (Suppl. 1): S1-S9. (Pubitemid 44903894)
6. Ministry of Public Health Thailand. Thailand Health Profile 2005-2007. (accessed 6 May 2011).
7. Pongcharoensuk P, et al,. Costs of diabetes patients in Thai government hospitals. Presented at: ISPOR 2nd Asia-Pacific Conference, Shanghai, China, 5-6 March 2006.
8. Putsook P,. Financial Expenditure of Patients with Diabetes Mellitus. Bangkok, Thailand: Faculty of Graduate Studies, Mahidol University, 1999 (dissertation).
9. Riewpaiboon A, et al,. Diabetes cost model of a hospital in Thailand. Value Health 2007; 10: 223-230. (Pubitemid 47077243)
10. Moolasarn S, et al,. Usage of and cost of complementary/alternative medicine in diabetic patients. J Med Assoc Thai 2005; 88: 1630-1637. (Pubitemid 44698980)
11. Brouwer W, et al,. Costing in economic evaluations. In:, Drummond M, McGuire A, eds. Economic Evaluation in Health Care: Merging Theory with Practice. New York: Oxford University Press, 2001: 68-93.
12. World Health Organization. International Classification of Diseases 10th Revision. Geneva: WHO, 2007. (accessed 6 May 2011).
13. Lwanga SK, Lemeshow S,. Sample Size Determination in Health Studies: A Practical Manual. Geneva: World Health Organization, 1991.
14. Krop JS, et al,. Patterns of expenditures and use of services among older adults with diabetes: implications for the transition to capitated managed care. Diabetes Care 1998; 21: 747-752. (Pubitemid 28487066)
15. Lin T, et al,. Predicting factors associated with costs of diabetic patients in Taiwan. Diabetes Res Clin Pract 2004; 63: 119-125. (Pubitemid 38096357)
16. Krop JS, et al,. Predicting expenditures for Medicare beneficiaries with diabetes: a prospective cohort study from 1994 to 1996. Diabetes Care 1999; 22: 1660-1666. (Pubitemid 29458389)
17. Bhattacharyya SK,. Predicting hospitalisation of patients with diabetes mellitus: an application of the Bayesian discriminant analysis. Pharmacoeconomics 1998; 13: 519-529. (Pubitemid 28239845)
18. Bhattacharyya SK, Else BA,. Medical costs of managed care in patients with type 2 diabetes mellitus. Clin Ther 1999; 21: 2131-2142. (Pubitemid 30043927)
19. Brown JB, et al,. The progressive cost of complications in type 2 diabetes mellitus. Arch Intern Med 1999; 159: 1873-1880. (Pubitemid 29424707)
20. Guo JJ, et al,. Empiric investigation on direct costs-of-illness and healthcare utilization of medicaid patients with diabetes mellitus. Am J Manag Care 1998; 4: 1433-1446. (Pubitemid 28506806)
21. Chaikledkaew U, et al,. Factors affecting health-care costs and hospitalizations among diabetic patients in Thai public hospitals. Value Health 2008; 11 (Suppl. 1): S69-S74. (Pubitemid 351490461)
22. Kobelt G,. Health Economics: An Introduction to Economic Evaluation. London: Office of Health Economics, 2002.
23. Chetthakul T, et al,. Thailand diabetes registry project: prevalence of diabetic retinopathy and associated factors in type 2 diabetes mellitus. J Med Assoc Thai 2006; 89 (Suppl. 1): S27-S36. (Pubitemid 44903897)
24. Krittiyawong S, et al,. Thailand diabetes registry project: prevalence and risk factors associated with lower extremity amputation in Thai diabetics. J Med Assoc Thai 2006; 89 (Suppl. 1): S43-S48. (Pubitemid 44903899)
25. Leelawattana R, et al,. Thailand diabetes registry project: prevalence of vascular complications in long-standing type 2 diabetes. J Med Assoc Thai 2006; 89 (Suppl. 1): S54-S59. (Pubitemid 44903901)
26. Ngarmukos C, et al,. Thailand diabetes registry project: prevalence, characteristics and treatment of patients with diabetic nephropathy. J Med Assoc Thai 2006; 89 (Suppl. 1): S37-S42. (Pubitemid 44903898)
27. Drummond M, et al,. Methods for the Economic Evaluation of Health Care Programmes, 3rd edn. Oxford: Oxford University Press, 2005.
28. Shepard DS, et al,. Analysis of Hospital Costs: A Manual for Managers. Geneva: World Health Organization, 2000.
29. Riewpaiboon A,. Institutional Cost Analysis. Bangkok: Mahidol University, 2003.
30. Edejer TT, et al,. Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis. Geneva: World Health Organization, 2003.
31. Cohen J, et al,. Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences, 3rd edn. Mahwah, NJ: Lawrence Erlbaum Associates Inc., 2003.
32. Finkler SA,. The distinction between cost and charges. Ann Intern Med 1982; 96: 102-109.
33. Suver JD, Cooper JC,. Principles and methods of managerial cost-accounting systems. Am J Hosp Pharm 1988; 45: 146-152.
34. Duan N,. Smearing estimator: a nonparametric retransformation method. J Am Stat Assoc 1983; 78: 605-610.
35. Riewpaiboon A, et al,. Economic burden of road traffic injuries: a micro-costing approach. Southeast Asian J Trop Med Public Health 2008; 39: 1139-1149.
36. Kongsawatt S,. Unit Cost Analysis of Medical Services in Five Provinces under the Health System Reform [in Thai]. Bangkok: Bureau of Health Policy and Planning, Ministry of Public Health, 1997.
37. Riewpaiboon A, et al,. A cost-function analysis of Shigellosis in Thailand. Value Health 2008; 11 (Suppl. 1): S75-S83.
38. O'Brien JA, et al,. Cost of managing complications resulting from type 2 diabetes mellitus in Canada. BMC Health Serv Res 2003; 3: 7.
39. Morsanutto A, et al,. Major diabetes complications have an impact on total annual medical cost of type 2 diabetes. Diabetes Care 2004; 27: 1841-1842. (Pubitemid 38857478)
40. Norlund A, et al,. Cost of illness of adult diabetes mellitus underestimated if comorbidity is not considered. J Intern Med 2001; 250: 57-65. (Pubitemid 34208939)
41. Pelletier EM, et al,. Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting: a resource for economic research. Appl Health Econ Health Policy 2008; 6: 103-112.
42. Shobhana R, et al,. Foot care economics-cost burden to diabetic patients with foot complications: a study from southern India. J Assoc Physicians India 2001; 49: 530-533. (Pubitemid 33639613)